Demetra Holding S.p.A.

Based in Italy, Demetra Holding S. p. A. provides specialized healthcare solutions, focusing on advanced surgical procedures and medical devices, including orthopedic and neurosurgical innovations through its subsidiaries.

Demetra Holding S. p. A. is a company that specializes in the healthcare sector, particularly in surgical solutions and medical devices.

It was founded in 2018 and is headquartered in Milan, Italy. The company has successfully completed three deals, with the most recent occurring on February 20, 2023. In February 2023, DeA Capital Alternative Funds and Alcedo SGR fully acquired Demetra Holding S. p.

A. for an undisclosed sum. The founder's history is not available. Demetra Holding S.

p. A. specializes in the healthcare sector, focusing on advanced surgical solutions and medical devices. Their core product offerings include innovative orthopedic and neurosurgical solutions developed by their subsidiary companies such as GetSet Surgical, Tecres, and OSARTIS GmbH.

GetSet Surgical provides spine surgical solutions that cater to hospitals and surgical centers, enhancing surgical precision and patient outcomes. Tecres offers products made from specialized acrylic resins aimed at orthopedic applications such as vertebroplasty and neuroradiology, while OSARTIS GmbH develops and markets biomaterials that assist in surgical procedures, addressing the needs of healthcare professionals and improving patient care. These products are distributed primarily in Europe and other international markets, targeting hospitals, surgical centers, and healthcare providers. Demetra Holding's revenue generation model is primarily anchored in B2B transactions with healthcare institutions, including hospitals and surgical centers.

In 2023, the company generated revenue of EUR 38,218,187. 70 and achieved an EBITDA of EUR 17,615,278. 70. The company engages in direct sales of its medical devices and surgical solutions, fostering partnerships with healthcare providers to ensure product integration in surgical practices.

Revenue is driven through the sale of specialized products, including those developed by their subsidiaries, which are often sold on a per-unit basis depending on the type of procedure and volume requirements. Flagship offerings such as the spine surgical solutions from GetSet Surgical and biomaterials from OSARTIS are key contributors to the company's revenue streams. Transactions are characterized by structured agreements, allowing for long-term relationships with clients and repeat business, ensuring continuous support and product supply in the healthcare market. Demetra Holding S.

p. A. is focused on growth through innovation and market expansion. Following the acquisition by DeA Capital Alternative Funds and Alcedo SGR, the company plans to enhance its production processes and expand its sales network across both European and non-European markets.

This includes the development of new products aimed at completing the product range to cover all main phases of farming by 2025. The recent investment will support these initiatives and enhance their capabilities in production and market reach.